The measurement of the biological activity of soluble recombinant human LIGHT has relied so far on the use of human tumor cell lines expressing either LTβR and/or HVEM [23, 33], or primary T cells expressing HVEM that can proliferate in response to LIGHT [34]. The gene discussed is TNFSF14; the disease is neoplasm.